Detection of epigenetic cytosine modification

Patent metadata

Field	Value
Publication number	US-2025361549-A1
Application number	US-202318873630-A
Country	US
Kind code	A1
Filing date	Jun 12, 2023
Priority date	Jun 14, 2022
Publication date	Nov 27, 2025
Grant date	—

Abstract

The invention includes improved methods and compositions for reduction of a C5-C6 double bond of a cytosine. In particular, the improved methods and compositions for reduction of a C5-C6 double bond of a cytosine is via enzymatic means, not via chemical means. In particular, the disclosure is directed to methods of converting 5,6-dihydro-fC (fC) and/or 5,6-dihydro-caC to 5,6-dihydro-U (DHU). In particular, the disclosure is directed to methods of converting 5fC and/or 5caC to DHU. In addition, the disclosure is directed to methods for detection of epigenetic cytosine modification, particularly cytosine methylation, using ene reductases to reduce the C5-C6 double bond of cytosine.

First claim

1 . A method for reducing a C5-C6 double bond of cytosine in a nucleic acid, wherein the method comprises contacting cytosine in the nucleic acid with an ene reductase.

2 . The method of claim 1 , wherein the cytosine is selected from the group consisting of 5-Formylcytosine (5fC), 5-Carboxylcytosine (5caC), 5,6-dihydro-fC, 5,6-dihydro-caC, 2′-Deoxy-5-formylcytidine, 2′-Deoxy-5-carobxycitidine, 5-Formyl-2′-deoxycytidine, 5-Formyl-dC, 5-Carboxy-2′-deoxycytidine, and 5-Carboxy-dC.

3 . The method of claim 1 , wherein contacting the cytosine in the nucleic acid with an ene reductase reduces the cytosine to 5,6-dihydro-U (DHU).

4 . The method of claim 3 , wherein the DHU is subsequently converted to a Thymine.

5 . The method of claim 1 , wherein reduction of the C5-C6 double bond of cytosine in the nucleic acid by contacting the cytosine in the nucleic acid with an ene reductase is a part of a method for detecting an epigenetic cytosine modification.

6 . A method for detecting an epigenetic cytosine modification, wherein the method comprises at least the step of reducing a C5-C6 double bond of a cytosine in a nucleic acid by contacting the cytosine in the nucleic acid with an ene reductase.

7 . The method of claim 6 , wherein the cytosine is selected from a group consisting of 5-Formylcytosine (5fC), 5-Carboxylcytosine (5caC), 5,6-dihydro-fC, 5,6-dihydro-caC, 2′-Deoxy-5-formylcytidine, 2′-Deoxy-5-carobxycitidine, 5-Formyl-2′-deoxycytidine, 5-Formyl-dC, 5-Carboxy-2′-deoxycytidine and 5-Carboxy-dC.

8 . The method of claim 6 , wherein contacting the cytosine in the nucleic acid with an ene reductase reduces the cytosine to 5,6-dihydro-U (DHU).

9 . The method of claim 8 , wherein the DHU is subsequently converted to a thymine.

10 . A method for detecting an epigenetic cytosine modification in a nucleic acid, the method comprising:
(a) converting an epigenetic cytosine modification in a nucleic acid to a first modified nucleotide having a C5-C6 double bond; (b) reducing with an ene reductase the C5-C6 double bond of the first modified nucleotide, thereby forming a second modified nucleotide; (c) converting the second modified cystosine to a third modified nucleotide detectable by a uracil-tolerant nucleic acid polymerase as a thymine; and (d) detecting the third modified nucleotide in the nucleic acid with the uracil-tolerant nucleic acid polymerase, thereby differentiating the epigenetic cytosine modification from an unmodified cytosine in the nucleic acid.

11 . The method of claim 10 , wherein the epigenetic cytosine modification is selected from 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), and wherein the first modified nucleotide is selected from 5-formylcytosine (5fC) and 5-carboxycytosine (5caC).

12 . The method of claim 10 , wherein a second modified nucleotide is selected from of 5,6-dihydro-formylcytosine and 5,6-dihydro-carboxycytosine.

13 . The method of claim 10 , wherein the third modified nucleotide is 5,6-dihydrouracil (DHU).

Assignees

• Roche Sequencing Solutions Inc

Inventors

• Heindl Dieter
• Bergmann Frank
• Chang Shwu Shin

Classifications

• G01N2333/90206

  acting on the CH-CH group of donors (1.3) · CPC title

• C12Q1/6806 Primary

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12Q1/26

  involving oxidoreductase · CPC title

• C12Q1/6827 Primary

  for detection of mutation or polymorphism · CPC title